Document is current
Any future updates will be listed below
-
Authors
Tan, Joel M. J. https://orcid.org/0000-0002-6051-3786
Melamed, Sarah
Cofsky, Joshua C.
Syangtan, Deepsing
Hobbs, Samuel J.
del Mármol, Josefina https://orcid.org/0000-0003-2715-0482
Jost, Marco https://orcid.org/0000-0002-1369-4908
Kruse, Andrew C. https://orcid.org/0000-0002-1467-1222
Sorek, Rotem https://orcid.org/0000-0002-3872-4982
Kranzusch, Philip J. https://orcid.org/0000-0002-4943-733X
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 23 April 2025
First Online: 30 April 2025
Competing interests
: R.S. is a scientific cofounder and advisor of BiomX and Ecophage. A.C.K. is a cofounder and consultant for Tectonic Therapeutic and Seismic Therapeutic and for the Institute for Protein Innovation, a non-profit research institute. M.J. declares outside interest in Evozyne and DEM BioPharma. The other authors declare no competing interests.
